The Kissick Family Foundation Frontotemporal Dementia (FTD) Grant Program will fund a fourth cohort of research studies to understand the fundamental biology of why and how sporadic forms of FTD develop.
ATF-LOMAS is a grant program that offers two-year grants to support early-career investigators studying sarcoidosis, plus mentorship to funded investigators.
ATF-SIM is a new grant program intended to support an investigator-initiated clinical trial to evaluate an mTOR inhibitor in cutaneous sarcoidosis.
For details on current requests for proposals and funding opportunities, please visit the Breakthrough Discoveries for thriving with Bipolar Disorder website.
ATF-LOMAS, a new grant program, will offer two-year grants to support early-career investigators studying sarcoidosis, plus mentorship to funded investigators.
Tambourine is launching the ALS Breakthrough Research Fund, which will support basic and discovery-focused research in amyotrophic lateral sclerosis (ALS).
The Ann Theodore Foundation Breakthrough Sarcoidosis Initiative (ATF-BSI) is now accepting applications in its fifth year for two-year research projects that seek to increase our foundational understanding of sarcoidosis through projects focused on the biology and epidemiology of sarcoidosis.
The Kissick Family Foundation Frontotemporal Dementia (FTD) Grant Program will fund a third cohort of research studies to understand the fundamental biology of why and how sporadic forms of FTD develop.
In collaboration with the Milken Institute Center for Strategic Philanthropy, the Fund is launching a new Metabolic Mind Award Program recognizing individual contributions in the emerging field of Metabolic Psychiatry.
For its fourth year, the MRF is now accepting applications for one- to two-year research projects that seek to better understand misophonia, diagnose people experiencing symptoms, and assess interventional strategies to treat people who have the disorder.
For its third year, the MRF is now accepting applications for one- to two-year research projects that seek to better understand misophonia, diagnose people who have the condition, and assess interventional strategies to treat people who have the condition.
The Ann Theodore Foundation is launching the fourth cycle of a scientific program focused on funding sarcoidosis research in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration.
Please note: SPARC is unable to accept unsolicited funding requests. We appreciate your interest in our work and encourage you to check back for any future opportunities or open calls for proposals.
The Kissick Family Foundation Frontotemporal Dementia (FTD) Grant Program will fund a fourth cohort of research studies to understand the fundamental biology of why and how sporadic forms of FTD develop.
ATF-SIM is a new grant program intended to support an investigator-initiated clinical trial to evaluate an mTOR inhibitor in cutaneous sarcoidosis.
For details on current requests for proposals and funding opportunities, please visit the Breakthrough Discoveries for thriving with Bipolar Disorder website.
ATF-LOMAS, a new grant program, will offer two-year grants to support early-career investigators studying sarcoidosis, plus mentorship to funded investigators.
Tambourine is launching the ALS Breakthrough Research Fund, which will support basic and discovery-focused research in amyotrophic lateral sclerosis (ALS).
The Ann Theodore Foundation Breakthrough Sarcoidosis Initiative (ATF-BSI) is now accepting applications in its fifth year for two-year research projects that seek to increase our foundational understanding of sarcoidosis through projects focused on the biology and epidemiology of sarcoidosis.
The Kissick Family Foundation Frontotemporal Dementia (FTD) Grant Program will fund a third cohort of research studies to understand the fundamental biology of why and how sporadic forms of FTD develop.
In collaboration with the Milken Institute Center for Strategic Philanthropy, the Fund is launching a new Metabolic Mind Award Program recognizing individual contributions in the emerging field of Metabolic Psychiatry.
For its fourth year, the MRF is now accepting applications for one- to two-year research projects that seek to better understand misophonia, diagnose people experiencing symptoms, and assess interventional strategies to treat people who have the disorder.
For its third year, the MRF is now accepting applications for one- to two-year research projects that seek to better understand misophonia, diagnose people who have the condition, and assess interventional strategies to treat people who have the condition.
The Ann Theodore Foundation is launching the fourth cycle of a scientific program focused on funding sarcoidosis research in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration.
The Kissick Family Foundation is launching the inaugural cycle of a scientific program focused on funding frontotemporal dementia (FTD) research in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (MI-SPARC).
The Kissick Family Foundation Frontotemporal Dementia (FTD) Grant Program will fund a fourth cohort of research studies to understand the fundamental biology of why and how sporadic forms of FTD develop.
ATF-LOMAS is a grant program that offers two-year grants to support early-career investigators studying sarcoidosis, plus mentorship to funded investigators.
ATF-SIM is a new grant program intended to support an investigator-initiated clinical trial to evaluate an mTOR inhibitor in cutaneous sarcoidosis.
For details on current requests for proposals and funding opportunities, please visit the Breakthrough Discoveries for thriving with Bipolar Disorder website.
ATF-LOMAS, a new grant program, will offer two-year grants to support early-career investigators studying sarcoidosis, plus mentorship to funded investigators.
Tambourine is launching the ALS Breakthrough Research Fund, which will support basic and discovery-focused research in amyotrophic lateral sclerosis (ALS).
The Ann Theodore Foundation Breakthrough Sarcoidosis Initiative (ATF-BSI) is now accepting applications in its fifth year for two-year research projects that seek to increase our foundational understanding of sarcoidosis through projects focused on the biology and epidemiology of sarcoidosis.
The Kissick Family Foundation Frontotemporal Dementia (FTD) Grant Program will fund a third cohort of research studies to understand the fundamental biology of why and how sporadic forms of FTD develop.
In collaboration with the Milken Institute Center for Strategic Philanthropy, the Fund is launching a new Metabolic Mind Award Program recognizing individual contributions in the emerging field of Metabolic Psychiatry.
For its fourth year, the MRF is now accepting applications for one- to two-year research projects that seek to better understand misophonia, diagnose people experiencing symptoms, and assess interventional strategies to treat people who have the disorder.
For its third year, the MRF is now accepting applications for one- to two-year research projects that seek to better understand misophonia, diagnose people who have the condition, and assess interventional strategies to treat people who have the condition.
The Ann Theodore Foundation is launching the fourth cycle of a scientific program focused on funding sarcoidosis research in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration.